| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 25 |
| 1 | ETANERCEPT | 15 |
| 2 | ADALIMUMAB-AATY | 13 |
| 3 | ADALIMUMAB-ADAZ | 13 |
| 4 | ADALIMUMAB-FKJP | 13 |
| 5 | INFLIXIMAB | 10 |
| 6 | INTERFERON BETA-1A | 9 |
| 7 | DIMETHYL FUMARATE | 7 |
| 8 | GLATIRAMER ACETATE | 7 |
| 9 | TERIFLUNOMIDE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NADOFARAGENE FIRADENOVEC-VNCG | 1 | 0.0019 |
| 1 | NORETHINDRONE AND ETHINYL ESTRADIOL | 1 | 0.0009 |
| 2 | GLATIRAMER ACETATE INJECTION | 4 | 0.0008 |
| 3 | FINGOLIMOD HYDROCHLORIDE | 4 | 0.0008 |
| 4 | BACILLUS CALMETTE-GUERIN | 1 | 0.0006 |
| 5 | FOLLITROPIN ALFA | 1 | 0.0005 |
| 6 | CHORIOGONADOTROPIN ALFA | 1 | 0.0004 |
| 7 | ESTROGEN | 1 | 0.0003 |
| 8 | UBROGEPANT | 2 | 0.0003 |
| 9 | ADALIMUMAB-FKJP | 13 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 1 | Gonadotropin [EPC] | 1 | 0.0005 |
| 2 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 4 | 0.0003 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 4 | Pyrimidine Synthesis Inhibitor [EPC] | 7 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 6 | Interferon beta [EPC] | 9 | 0.0000 |
| 7 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 25 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 6 | 0.0000 |